Παρακαλώ χρησιμοποιήστε αυτό το αναγνωριστικό για να παραπέμψετε ή να δημιουργήσετε σύνδεσμο προς αυτό το τεκμήριο:
https://hdl.handle.net/10442/19824
| Εξειδίκευση τύπου : | Άρθρο σε επιστημονικό περιοδικό |
| Τίτλος: | Thrombotic and cardiovascular events in HIV infection (Review) |
| Δημιουργός/Συγγραφέας: | Dryllis, Georgios Vasilopoulou, Mavra Politou, Marianna Gerogkiokas, Achilleas Pittaras, Theodoros [EL] Ζουμπουρλής, Βασίλης[EN] Zoumpourlis, Vassilis [EL] Σπαντίδος, Δημήτριος Α.[EN] Spandidos, Demetrios A. Gialeraki, Argyri |
| Ημερομηνία: | 2025-07 |
| Γλώσσα: | Αγγλικά |
| ISSN: | 2049-9434 2049-9442 |
| DOI: | 10.3892/br.2025.2000 |
| Άλλο: | 40496191 |
| Περίληψη: | Human Immunodeficiency Virus (HIV) infection has nowadays become a chronic disease, due to the introduction of antiretroviral therapy (ART), which has improved both life expectancy and quality of life of patients with HIV but has also led to the emergence of previously unrecognized complications. Thromboembolic events constitute a serious and frequent comorbidity in patients with HIV. The thrombogenic potential of HIV infection is multifactorial and is attributed to persistent chronic inflammation, endothelial dysfunction and ART itself, mainly through the resulting metabolic alterations. Co-infections and gut microbe translocation observed in patients with HIV, also maintain the inflammatory prothrombotic microenvironment. Individuals with HIV are at higher risk for venous thromboembolism and cardiovascular disease, compared with general population. Among patients with HIV, those receiving specific ART regimens have a significant higher risk for myocardial infraction. HIV infection is also involved in other coagulation disorders, such as heparin-induced thrombocytopenia and thrombotic thrombocytopenic purpura. Therapeutic choices do not differ from individuals without HIV but should be cautiously administered due to drug interactions. Further studies are required in order to fully understand the pathophysiological mechanisms involved and develop new treatment options for patients with HIV. |
| Τίτλος πηγής δημοσίευσης: | Biomedical reports |
| Τόμος/Κεφάλαιο: | 23 |
| Τεύχος: | 1 |
| Θεματική Κατηγορία: | [EL] Ιατρική-Δημόσια υγεία[EN] Medicine - public aspects [EL] Δημόσια υγεία. Υγιεινή. Προληπτική ιατρική[EN] Public health. Hygiene. Preventive medicine [EL] Βιοχημεία[EN] Biochemistry [EL] Ανοσολογία[EN] Immunology [EL] Μικροβιολογία[EN] Microbiology [EL] Ιολογία[EN] Virology |
| Λέξεις-Κλειδιά: | HIV antiretroviral therapy cardiovascular disease venous thromboembolism |
| Κάτοχος πνευματικών δικαιωμάτων: | © Dryllis et al |
| Όροι και προϋποθέσεις δικαιωμάτων: | This is an open access article distributed under the terms of Creative Commons Attribution License. |
| Ηλεκτρονική διεύθυνση στον εκδότη (link): | https://doi.org/10.3892/br.2025.2000 |
| Εμφανίζεται στις συλλογές: | Ινστιτούτο Χημικής Βιολογίας - Επιστημονικό έργο
|